Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Izabela Hawro, Samuel M. Lee, Rhonda Denise Kineman, José Córdoba‐Chacón
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Methionine metabolism in mammals
10.1016/0955-2863(90)90070-2 · 1990
Methionine cycle in nonalcoholic fatty liver disease and its potential applications
10.1016/j.bcp.2022.115033 · 2022
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma
10.1016/s0168-8278(00)80122-1 · 2000
Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver
10.1073/pnas.91.1.210 · 1994
Phosphatidylethanolamine N-methyltransferase from liver
10.1016/s0005-2760(97)00108-2 · 1997
S-Adenosylmethionine: a control switch that regulates liver function
10.1096/fj.01-0401rev · 2002
Rosiglitazone requires hepatocyte PPARγ expression to promote steatosis in male mice with diet-induced obesity
2021
Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic fatty liver disease
10.1371/journal.pone.0136822 · 2015
Loss of glycine N-methyltransferase associates with angiopoietin-like protein 8 expression in high fat-diet-fed mice
10.3390/ijms20174223 · 2019
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice
10.1002/hep.22159 · 2008
Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline
10.1042/bj20021523 · 2003
Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas
10.1074/jbc.m111.265348 · 2011
Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice
10.1530/joe-16-0447 · 2017
Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice
10.1016/j.bbrc.2005.08.070 · 2005
Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction
10.1210/jc.2010-2129 · 2011
Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice
10.1007/s00018-022-04629-z · 2023
Dual outcomes of rosiglitazone treatment on fatty liver
10.1208/s12248-016-9919-9 · 2016
Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass
10.1074/jbc.m300043200 · 2003
Diet modifies Pioglitazone’s influence on hepatic PPARγ-regulated mitochondrial gene expression
10.1155/2020/3817573 · 2020
Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
10.1096/fj.10-173716 · 2011
Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression
10.1074/jbc.m210062200 · 2003
Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
10.1172/jci200317223 · 2003
Role of hepatic peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease
2023
Hepatocyte-specific loss of PPARγ protects mice from NASH and increases the therapeutic effects of rosiglitazone in the liver
10.1016/j.jcmgh.2021.01.003 · 2021
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review
10.1186/1475-2891-13-17 · 2014
PPARs in liver physiology
10.1016/j.bbadis.2021.166097 · 2021
Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting
10.1016/j.cmet.2023.07.002 · 2023
Effect of fasting on methionine adenosyltransferase expression and the methionine cycle in the mouse liver
10.3177/jnsv.51.118 · 2005
Regulation of homocysteine homeostasis through the transcriptional coactivator PGC-1alpha
2009
Differential impact of selective GH deficiency and endogenous GH excess on insulin-mediated actions in muscle and liver of male mice
10.1152/ajpendo.00420.2014 · 2014
Somatostatin and its receptors contribute in a tissue-specific manner to the sex-dependent metabolic (fed/fasting) control of growth hormone axis in mice
10.1152/ajpendo.00514.2010 · 2011
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
10.1186/gb-2002-3-7-research0034 · 2002
HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer
10.1038/s41467-020-17818-w · 2020
S-adenosylmethionine in liver health, injury, and cancer
10.1152/physrev.00047.2011 · 2012
S-adenosylmethionine metabolism and liver disease
10.1016/s1665-2681(19)31355-9 · 2013
S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver
10.1096/fj.00-0121com · 2000
Methionine as a regulator of bone remodeling with fasting
10.1172/jci.insight.177997 · 2024
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways
10.1172/jci11596 · 2001
AMPK-PPARγ-Cidec axis drives the fasting-induced lipid droplet aggregation in the liver of obese mice
10.3389/fnut.2022.917801 · 2022
Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention
10.1152/physiolgenomics.00179.2010 · 2011
Elevated homocysteine is associated with liver fibrosis in metabolic dysfunction-associated steatotic liver disease in a sex- and menopause-specific manner
10.1016/j.gastha.2025.100800 · doi-reference
Association of hepatic global DNA methylation and serum one-carbon metabolites with histological severity in patients with NAFLD
10.1002/oby.22667 · doi-reference
Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease
10.1111/j.1440-1746.2005.03891.x · doi-reference
Association between homocysteine and non-alcoholic fatty liver disease in Chinese adults: a cross-sectional study
10.1186/s12937-016-0221-6 · doi-reference
Hepatocyte-specific PPARγ deletion uncovers role of an antagonistic PPARγ-HNF4α transcriptional axis in metabolic dysfunction-associated steatotic liver disease progression
10.1016/j.ajpath.2026.04.015 · doi-reference
Hepatic methionine homeostasis is conserved in C57BL/6N mice on high-fat diet despite major changes in hepatic one-carbon metabolism
10.1371/journal.pone.0057387 · doi-reference
Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention
10.1152/physiolgenomics.00179.2010 · doi-reference
AMPK-PPARγ-Cidec axis drives the fasting-induced lipid droplet aggregation in the liver of obese mice
10.3389/fnut.2022.917801 · doi-reference
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways
10.1172/jci11596 · doi-reference
Methionine as a regulator of bone remodeling with fasting
10.1172/jci.insight.177997 · doi-reference
S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver
10.1096/fj.00-0121com · doi-reference
S-adenosylmethionine metabolism and liver disease
10.1016/s1665-2681(19)31355-9 · doi-reference
S-adenosylmethionine in liver health, injury, and cancer
10.1152/physrev.00047.2011 · doi-reference
HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer
10.1038/s41467-020-17818-w · doi-reference
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
10.1186/gb-2002-3-7-research0034 · doi-reference
Somatostatin and its receptors contribute in a tissue-specific manner to the sex-dependent metabolic (fed/fasting) control of growth hormone axis in mice
10.1152/ajpendo.00514.2010 · doi-reference
Differential impact of selective GH deficiency and endogenous GH excess on insulin-mediated actions in muscle and liver of male mice
10.1152/ajpendo.00420.2014 · doi-reference
Effect of fasting on methionine adenosyltransferase expression and the methionine cycle in the mouse liver
10.3177/jnsv.51.118 · doi-reference
Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting
10.1016/j.cmet.2023.07.002 · doi-reference
PPARs in liver physiology
10.1016/j.bbadis.2021.166097 · doi-reference
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review
10.1186/1475-2891-13-17 · doi-reference
Hepatocyte-specific loss of PPARγ protects mice from NASH and increases the therapeutic effects of rosiglitazone in the liver
10.1016/j.jcmgh.2021.01.003 · doi-reference
Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
10.1172/jci200317223 · doi-reference
Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression
10.1074/jbc.m210062200 · doi-reference
Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
10.1096/fj.10-173716 · doi-reference
Diet modifies Pioglitazone’s influence on hepatic PPARγ-regulated mitochondrial gene expression
10.1155/2020/3817573 · doi-reference
Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass
10.1074/jbc.m300043200 · doi-reference
Dual outcomes of rosiglitazone treatment on fatty liver
10.1208/s12248-016-9919-9 · doi-reference
Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice
10.1007/s00018-022-04629-z · doi-reference
Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction
10.1210/jc.2010-2129 · doi-reference
Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice
10.1016/j.bbrc.2005.08.070 · doi-reference
Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice
10.1530/joe-16-0447 · doi-reference
Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas
10.1074/jbc.m111.265348 · doi-reference
Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline
10.1042/bj20021523 · doi-reference
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice
10.1002/hep.22159 · doi-reference
Loss of glycine N-methyltransferase associates with angiopoietin-like protein 8 expression in high fat-diet-fed mice
10.3390/ijms20174223 · doi-reference
Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic fatty liver disease
10.1371/journal.pone.0136822 · doi-reference
S-Adenosylmethionine: a control switch that regulates liver function
10.1096/fj.01-0401rev · doi-reference
Phosphatidylethanolamine N-methyltransferase from liver
10.1016/s0005-2760(97)00108-2 · doi-reference
Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver
10.1073/pnas.91.1.210 · doi-reference